ALIMERA SCIENCES INC·4

Oct 2, 4:28 PM ET

Kaba Samer 4

4 · ALIMERA SCIENCES INC · Filed Oct 2, 2019

Insider Transaction Report

Form 4
Period: 2019-09-30
Kaba Samer
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2019-09-30$0.57/sh+1,249$71273,985 total
Footnotes (1)
  • [F1]These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2019.

Documents

1 file
  • 4
    wf-form4_157004808199127.xmlPrimary

    FORM 4